These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3632181)

  • 21. Cardiovascular effects on selective perfusion of the fourth cerebral ventricle in cats with fentanyl, naloxone & methohexital.
    Freye E; Gupta BN
    Indian J Exp Biol; 1980 Jan; 18(1):29-31. PubMed ID: 7399575
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of fentanyl on arginine vasopressin and cortisol secretion during anesthesia.
    Lehtinen AM; Fyhrquist F; Kivalo I
    Anesth Analg; 1984 Jan; 63(1):25-30. PubMed ID: 6691560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selective attention and memory: evoked potentials in visual and auditory verbal competition].
    Ivanitskiĭ AM; Il'iuchenok IR; Ivanitskiĭ GA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(5):541-51. PubMed ID: 14658318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs.
    Flacke JW; Flacke WE; Bloor BC; Olewine S
    Anesth Analg; 1983 Mar; 62(3):305-13. PubMed ID: 6829930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of auditory-evoked potentials in musicians reflects an influence of expertise but not selective attention.
    Baumann S; Meyer M; Jäncke L
    J Cogn Neurosci; 2008 Dec; 20(12):2238-49. PubMed ID: 18457513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of opioid peptides in disorders of attention in psychopathology.
    Buchsbaum MS; Reus VI; Davis GC; Holcomb HH; Cappelletti J; Silberman E
    Ann N Y Acad Sci; 1982; 398():352-65. PubMed ID: 6297359
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neurophysiological analysis of analgesic effect of phentanyl and moradol].
    Meizerov EE; Blinov AV; Reshetniak VK
    Anesteziol Reanimatol; 1996; (4):10-3. PubMed ID: 8975560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective attention and audiovisual integration: is attending to both modalities a prerequisite for early integration?
    Talsma D; Doty TJ; Woldorff MG
    Cereb Cortex; 2007 Mar; 17(3):679-90. PubMed ID: 16707740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential impairments of selective attention due to frequency and duration of cannabis use.
    Solowij N; Michie PT; Fox AM
    Biol Psychiatry; 1995 May; 37(10):731-9. PubMed ID: 7640328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent influences on ERP indicators of attention after neuropeptide ACTH 4-10.
    Born J; Fehm-Wolfsdorf G; Pauschinger P; Fehm HL
    Electroencephalogr Clin Neurophysiol Suppl; 1987; 40():509-13. PubMed ID: 2826106
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical evaluation of naloxone].
    Cattaneo AD; Rivara A; Siani C; Graffigna R
    Minerva Anestesiol; 1977 Jun; 43(6):335-43. PubMed ID: 909636
    [No Abstract]   [Full Text] [Related]  

  • 33. Cortisol effects on attentional processes in man as indicated by event-related potentials.
    Born J; Kern W; Fehm-Wolfsdorf G; Fehm HL
    Psychophysiology; 1987 May; 24(3):286-92. PubMed ID: 3602284
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure of naloxone to modify the depth of hypnotic trance.
    Spruiell G; Steck C; Lippincott CK; King C
    Experientia; 1983 Jul; 39(7):763-4. PubMed ID: 6861967
    [No Abstract]   [Full Text] [Related]  

  • 35. [The endogenous opioid system and selective attention].
    Castañeda-Trujillo R
    Gac Med Mex; 1989; 125(3-4):89-95; discussion 96. PubMed ID: 2561281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of fentanyl and naloxone on somatic and auditory evoked potentials in man.
    Velasco M; Velasco F; Castañeda R; Sánchez R
    Proc West Pharmacol Soc; 1983; 26():291-4. PubMed ID: 6889357
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of fentanyl and naloxone on human somatic and auditory-evoked potential components.
    Velasco M; Velasco F; Castañeda R; Sánchez R
    Neuropharmacology; 1984 Mar; 23(3):359-66. PubMed ID: 6728127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fentanyl and naloxone on the P300 auditory potential.
    Velasco M; Velasco F; Castañeda R; Lee M
    Neuropharmacology; 1984 Aug; 23(8):931-8. PubMed ID: 6483118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fentanyl and naloxone on early and late components of the auditory evoked potentials.
    Castañeda R; Velasco M; Sánchez R; Dávila A
    Arch Invest Med (Mex); 1987; 18(1):51-67. PubMed ID: 3632181
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.